-
1
-
-
0025116298
-
Extracerebral manifestations in migraine. A peptidergic involvement?
-
Edvinsson L, Goadsby PJ. Extracerebral manifestations in migraine. A peptidergic involvement?. J Intern Med. 1990; 228: 299-304
-
(1990)
J Intern Med
, vol.228
, pp. 299-304
-
-
Edvinsson, L.1
Goadsby, P.J.2
-
2
-
-
0025143541
-
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
-
Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990; 28: 183-187
-
(1990)
Ann Neurol
, vol.28
, pp. 183-187
-
-
Goadsby, P.J.1
Edvinsson, L.2
Ekman, R.3
-
3
-
-
78650413846
-
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
-
Hansen JM, Hauge AW, Olesen J, et al. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010; 30: 1179-1186
-
(2010)
Cephalalgia
, vol.30
, pp. 1179-1186
-
-
Hansen, J.M.1
Hauge, A.W.2
Olesen, J.3
-
4
-
-
0034649442
-
Plasma levels of calcitonin gene-related peptide in chronic tension-type headache
-
Ashina M, Bendtsen L, Jensen R, et al. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology. 2000; 55: 1335-1340
-
(2000)
Neurology
, vol.55
, pp. 1335-1340
-
-
Ashina, M.1
Bendtsen, L.2
Jensen, R.3
-
5
-
-
77957922955
-
CGRP and its receptors provide new insights into migraine pathophysiology
-
Ho TW, Edvinsson L, Goadsby PJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol. 2010; 6: 573-582
-
(2010)
Nat Rev Neurol
, vol.6
, pp. 573-582
-
-
Ho, T.W.1
Edvinsson, L.2
Goadsby, P.J.3
-
6
-
-
1542346238
-
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine
-
Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004; 350: 1104-1110
-
(2004)
N Engl J Med
, vol.350
, pp. 1104-1110
-
-
Olesen, J.1
Diener, H.C.2
Husstedt, I.W.3
-
7
-
-
57649233374
-
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: A randomised, placebo-controlled, parallel-treatment trial
-
Ho TW, Ferrari MD, Dodick DW, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: A randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008; 372: 2115-2123
-
(2008)
Lancet
, vol.372
, pp. 2115-2123
-
-
Ho, T.W.1
Ferrari, M.D.2
Dodick, D.W.3
-
8
-
-
79954607744
-
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
-
Hewitt DJ, Aurora SK, Dodick DW, et al. Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia. 2011; 31: 712-722
-
(2011)
Cephalalgia
, vol.31
, pp. 712-722
-
-
Hewitt, D.J.1
Aurora, S.K.2
Dodick, D.W.3
-
9
-
-
0031106389
-
Calcitonin gene-related peptide and reperfusion injury
-
Allen DM, Chen LE, Seaber AV, et al. Calcitonin gene-related peptide and reperfusion injury. J Orthop Res. 1997; 15: 243-248
-
(1997)
J Orthop Res
, vol.15
, pp. 243-248
-
-
Allen, D.M.1
Chen, L.E.2
Seaber, A.V.3
-
10
-
-
0032076264
-
Calcitonin gene-related peptide in myocardial ischaemia and reperfusion in the pig
-
Källner G, Gonon A, Franco-Cereceda A. Calcitonin gene-related peptide in myocardial ischaemia and reperfusion in the pig. Cardiovasc Res. 1998; 38: 493-499
-
(1998)
Cardiovasc Res
, vol.38
, pp. 493-499
-
-
Källner, G.1
Gonon, A.2
Franco-Cereceda, A.3
-
11
-
-
78650763344
-
Effect of calcitonin gene-related peptide receptor antagonism on the systemic blood pressure responses to mechanistically diverse vasomodulators in conscious rats
-
Lynch JJ, Detwiler TJ, Kane SA, et al. Effect of calcitonin gene-related peptide receptor antagonism on the systemic blood pressure responses to mechanistically diverse vasomodulators in conscious rats. J Cardiovasc Pharmacol. 2010; 56: 518-525
-
(2010)
J Cardiovasc Pharmacol
, vol.56
, pp. 518-525
-
-
Lynch, J.J.1
Detwiler, T.J.2
Kane, S.A.3
-
12
-
-
23944444767
-
Calcitonin gene-related peptide and substance P contribute to reduced blood pressure in sympathectomized rats
-
Supowit SC, Ethridge RT, Zhao H, et al. Calcitonin gene-related peptide and substance P contribute to reduced blood pressure in sympathectomized rats. Am J Physiol Heart Circ Physiol. 2005; 289: H1169-H1175
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.289
, pp. 1169-H1175
-
-
Supowit, S.C.1
Ethridge, R.T.2
Zhao, H.3
-
13
-
-
77956233522
-
Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries
-
Chan KY, Edvinsson L, Eftekhari S, et al. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries. J Pharmacol Exp Ther. 2010; 334: 746-752
-
(2010)
J Pharmacol Exp Ther
, vol.334
, pp. 746-752
-
-
Chan, K.Y.1
Edvinsson, L.2
Eftekhari, S.3
-
14
-
-
70350335038
-
Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs
-
Lynch JJ, Shen YT, Pittman TJ, et al. Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs. Eur J Pharmacol. 2009; 623: 96-102
-
(2009)
Eur J Pharmacol
, vol.623
, pp. 96-102
-
-
Lynch, J.J.1
Shen, Y.T.2
Pittman, T.J.3
-
15
-
-
13244252481
-
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers
-
Petersen KA, Birk S, Lassen LH, et al. The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia. 2005; 25: 139-147
-
(2005)
Cephalalgia
, vol.25
, pp. 139-147
-
-
Petersen, K.A.1
Birk, S.2
Lassen, L.H.3
-
16
-
-
79953840319
-
The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men
-
Van der Schueren BJ, Blanchard R, Murphy MG, et al. The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men. Br J Clin Pharmacol. 2011; 71: 708-717
-
(2011)
Br J Clin Pharmacol
, vol.71
, pp. 708-717
-
-
Van Der Schueren, B.J.1
Blanchard, R.2
Murphy, M.G.3
-
17
-
-
84857232404
-
A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina
-
Chaitman BR, Ho AP, Behm MO, et al. A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina. Clin Pharmacol Ther. 2012; 91: 459-466
-
(2012)
Clin Pharmacol Ther
, vol.91
, pp. 459-466
-
-
Chaitman, B.R.1
Ho, A.P.2
Behm, M.O.3
-
18
-
-
84884151958
-
Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development
-
Bigal ME, Walter S, Rapoport AM. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development. Headache. 2013; 53: 1230-1244
-
(2013)
Headache
, vol.53
, pp. 1230-1244
-
-
Bigal, M.E.1
Walter, S.2
Rapoport, A.M.3
-
19
-
-
84901494275
-
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
-
Bigal ME, Escandon R, Bronson M, et al. Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program. Cephalalgia.:
-
Cephalalgia
-
-
Bigal, M.E.1
Escandon, R.2
Bronson, M.3
-
21
-
-
0021999238
-
Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin
-
Lundberg JM, Franco-Cereceda A, Hua X, et al. Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol. 1985; 108: 315-319
-
(1985)
Eur J Pharmacol
, vol.108
, pp. 315-319
-
-
Lundberg, J.M.1
Franco-Cereceda, A.2
Hua, X.3
-
22
-
-
78149252258
-
Calcitonin gene-related peptide receptor antagonists and triptans: A tale of two treatments
-
Goadsby PJ. Calcitonin gene-related peptide receptor antagonists and triptans: A tale of two treatments. Neurology. 2010; 75: 1494-1495
-
(2010)
Neurology
, vol.75
, pp. 1494-1495
-
-
Goadsby, P.J.1
-
23
-
-
84871261412
-
Emerging target-based paradigms to prevent and treat migraine
-
Silberstein SD. Emerging target-based paradigms to prevent and treat migraine. Clin Pharmacol Ther. 2013; 93: 78-85
-
(2013)
Clin Pharmacol Ther
, vol.93
, pp. 78-85
-
-
Silberstein, S.D.1
-
24
-
-
84857633644
-
New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors
-
Hoffmann J, Goadsby PJ. New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors. Curr Treat Options Neurol. 2012; 14: 50-59
-
(2012)
Curr Treat Options Neurol
, vol.14
, pp. 50-59
-
-
Hoffmann, J.1
Goadsby, P.J.2
-
25
-
-
77949687406
-
Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist
-
Salvatore CA, Moore EL, Calamari A, et al. Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist. J Pharmacol Exp Ther. 2010; 333: 152-160
-
(2010)
J Pharmacol Exp Ther
, vol.333
, pp. 152-160
-
-
Salvatore, C.A.1
Moore, E.L.2
Calamari, A.3
-
26
-
-
84892162373
-
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
-
Marcus R, Goadsby PJ, Dodick D, et al. BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial. Cephalalgia. 2014; 34: 114-125
-
(2014)
Cephalalgia
, vol.34
, pp. 114-125
-
-
Marcus, R.1
Goadsby, P.J.2
Dodick, D.3
-
27
-
-
0036257940
-
BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: Comparison with CGRP(8-37)
-
Verheggen R, Bumann K, Kaumann AJ. BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: Comparison with CGRP(8-37). Br J Pharmacol. 2002; 136: 120-126
-
(2002)
Br J Pharmacol
, vol.136
, pp. 120-126
-
-
Verheggen, R.1
Bumann, K.2
Kaumann, A.J.3
-
28
-
-
3042597423
-
Vascular actions of calcitonin gene-related peptide and adrenomedullin
-
Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004; 84: 903-934
-
(2004)
Physiol Rev
, vol.84
, pp. 903-934
-
-
Brain, S.D.1
Grant, A.D.2
-
29
-
-
0021997471
-
Calcitonin gene-related peptide is a potent vasodilator
-
Brain SD, Williams TJ, Tippins JR, et al. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985; 313: 54-56
-
(1985)
Nature
, vol.313
, pp. 54-56
-
-
Brain, S.D.1
Williams, T.J.2
Tippins, J.R.3
-
30
-
-
0023874663
-
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
-
Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988; 23: 193-196
-
(1988)
Ann Neurol
, vol.23
, pp. 193-196
-
-
Goadsby, P.J.1
Edvinsson, L.2
Ekman, R.3
-
31
-
-
0027971073
-
The effect of calcitonin gene-related peptide on ischemic reperfusion-induced arrhythmias in rats
-
Zhang JF, Liu J, Liu XZ, et al. The effect of calcitonin gene-related peptide on ischemic reperfusion-induced arrhythmias in rats. Int J Cardiol. 1994; 46: 33-36
-
(1994)
Int J Cardiol
, vol.46
, pp. 33-36
-
-
Zhang, J.F.1
Liu, J.2
Liu, X.Z.3
-
32
-
-
0034096267
-
Calcitonin gene-related peptide enhances the recovery of contractile function in stunned myocardium
-
Atkins BZ, Silvestry SC, Samy RN, et al. Calcitonin gene-related peptide enhances the recovery of contractile function in stunned myocardium. J Thorac Cardiovasc Surg. 2000; 119: 1246-1254
-
(2000)
J Thorac Cardiovasc Surg
, vol.119
, pp. 1246-1254
-
-
Atkins, B.Z.1
Silvestry, S.C.2
Samy, R.N.3
-
33
-
-
0036210058
-
Delayed cardioprotection induced by nitroglycerin is mediated by alpha-calcitonin gene-related peptide
-
Zhou ZH, Peng J, Ye F, et al. Delayed cardioprotection induced by nitroglycerin is mediated by alpha-calcitonin gene-related peptide. Naunyn Schmiedebergs Arch Pharmacol. 2002; 365: 253-259
-
(2002)
Naunyn Schmiedebergs Arch Pharmacol
, vol.365
, pp. 253-259
-
-
Zh, Z.1
Peng, J.2
Ye, F.3
-
34
-
-
84908189251
-
Cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against CGRP
-
Walter S, Bronson M, Escandon R, et al. Cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against CGRP. American Academy of Neurology.:
-
American Academy of Neurology
-
-
Walter, S.1
Bronson, M.2
Escandon, R.3
-
35
-
-
77957830531
-
Electrocardiographic assessment for therapeutic proteins-scientific discussion
-
Rodriguez I, Erdman A, Padhi D, et al. Electrocardiographic assessment for therapeutic proteins-scientific discussion. Am Heart J. 2010; 160: 627-634
-
(2010)
Am Heart J
, vol.160
, pp. 627-634
-
-
Rodriguez, I.1
Erdman, A.2
Padhi, D.3
-
36
-
-
0022452273
-
Antagonism by some ergot derivatives of 5-HT-induced vasoconstriction
-
Conolan S, Taylor DA. Antagonism by some ergot derivatives of 5-HT-induced vasoconstriction. Eur J Pharmacol. 1986; 123: 299-302
-
(1986)
Eur J Pharmacol
, vol.123
, pp. 299-302
-
-
Conolan, S.1
Taylor, D.A.2
-
37
-
-
0005556702
-
Augmented contraction of the human isolated coronary artery by sumatriptan: A possible role for endogenous thromboxane
-
Maassen VanDenBrink A, Bax WA, Ferrari MD, et al. Augmented contraction of the human isolated coronary artery by sumatriptan: A possible role for endogenous thromboxane. Br J Pharmacol. 1996; 119: 855-862
-
(1996)
Br J Pharmacol
, vol.119
, pp. 855-862
-
-
Maassen Vandenbrink, A.1
Bax, W.A.2
Ferrari, M.D.3
-
38
-
-
0030905854
-
Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: Outcome of two independent studies using different experimental protocols
-
Longmore J, Hargreaves RJ, Boulanger CM, et al. Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: Outcome of two independent studies using different experimental protocols. Funct Neurol. 1997; 12: 3-9
-
(1997)
Funct Neurol
, vol.12
, pp. 3-9
-
-
Longmore, J.1
Hargreaves, R.J.2
Boulanger, C.M.3
|